Navigation Links
Examples of Electro-Transfected Eukaryotic and Prokaryotic Cells


Mammalian
Hamster fibroblast (CHO)
Human B
Human, B lymphomas: BJAB,P3HR-1, B95-8, UC729-6
Human, B-cell, JY, Epstein-Barr virus transformed
Human, C-4I, cervical carcinoma
Human epithelial cells
Human erythroleukemia (K-562)
Human, epithelial, cervix (HeLa)
Human fibroblast
Human, GCT, fibrous histocytoma
Human glioblastoma
Human, HEL cells, eythroleukemia
Human, Hep3b2, hepatocytes
Human, HepG2, hepatoma
Human, HL 60, eythroleukemia
Human hybridoma
Human, JEG-3, choriocarcinoma
Human, K562, chronic myeloid leukemia
Human, kidney, 293
Human, lymphocytes, primary
Human lymphoma EB4, Ly67, HUT-78
Human, MCF-7, breast
Human, MRC-5, lung
Human medullary thyroid (MTC)
Human melanoma (SKMEL 25, SKMEL 28)
Human, pancreatic
Human primary monocytes
Human, Raji, Burkitt lymphoma
Human, red blood cells
Human, skin carcinoma
Human, squamous cell carcinoma, oral and cervical lines
Human, T lymphoma (Jurkat)
Human, T lymphoblastoid, CEMx174
Human, TCCSUP (epithelial-like) bladder carcinoma
Human, U373, glioblastoma
Human, U937, hystiocytic lymphoma
Human, V79, skin cel
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
2. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
3. Simple and Rapid Isolation of Plant RNA Using the Eppendorf Perfect RNA, Eukaryotic, Maxi Kit
4. Bacterial RNA Isolation From Infected Eukaryotic Hosts
5. Bacterial RNA Isolation From Infected Eukaryotic Hosts
6. Efficient Cloning and Electro-transformation of Large Eukaryotic DNA Fragments
7. An Epitope Tagging Vector for Gene Expression in Mammalian Cells
8. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
9. Cell Proliferation Kit Outperforms the Competition in the Range of Cells Typically Counted
10. XL10-Gold Cells Supplied in New Single-Reaction Format
11. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection

Post Your Comments:
(Date:11/23/2009)...3/PRNewswire/--Frost&Sullivan,theGrowthPartner...tingleadershipandinnovationThursday,November19,200...theldinSanAntonio,Texas. ,, (Logo: http://www.n...eHealthcareInnovationAwardsaregiventocompaniesthat...nagementofhealthcare.Suchcompanieshaveshownsuccess...
(Date:11/23/2009)...re-FirstCall/--CornerstoneTherapeuticsInc.(Nasdaq:...quiring,developingandcommercializingsignificantpro...odayannouncedthatCraigA.Collard,PresidentandChiefE...atthe21stAnnualPiperJaffrayHealthCareConferenceat3...eHotelinNewYorkCity. ,, Aliveaudioandarchivedwe...
(Date:11/20/2009)...ies have an opportunity to take the lead in two sm...iversity of Valencia (UV), working together with t... fabric of the Spanish biotechnology industry. The...rs have more clout than those in English-speaking ...d plants has been overlooked by the leading countr...
(Date:11/20/2009)...ewswire-FirstCall/ -- Dendreon Corporation (Nasdaq...rug Administration (FDA) provided written acknowle...se Application (BLA) for PROVENGE® (sipuleuce... a Prescription Drug User Fee Act (PDUFA) date of ...reon,s amended BLA. Dendreon is seeking licensure...
Breaking Biology Technology:Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3
...l 25 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...nded March 31, 2008., For the quarter ended March...9 million, or $0.53 per share. This compares to a ... the prior quarter ended December 31, 2007,and $55...er in 2007., For the quarter ended March 31, 2008...
...ntists and Collaborators Publish Study in Science,...bH, the,leading developer of RAFT intervention the...per in Science demonstrating a potential novel str...and other diseases by targeting,discrete sub-compa...nducted,by JADO scientists together with several a...
...lif., April 24 ,Exelixis, Inc. (Nasdaq: EXEL ) an...t and chief executive officer of Exelixis, will pr...ugged Conference at 3:40 p.m. ET/12:40,p.m. PT on ...s updates to,the company,s development pipeline an...ebcast and may be accessed in the Event,Calendar p...
Other Biology Technology:CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 1Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 3Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 1Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...ing environmental study to be published in a prest...y atmospheric emissions will end up in fish in as ...ity of Alberta in Edmonton, Canada, played a key r..., The study concludes that if mercury emissions f...ctivities were to be cut immediately, the amount s...
...CScientists are working to produce cheap, sustaina...gy researchers like California Institute of Techno...materials that mimic the architecture of grass and...gy. , A new podcast looks at how Dr. Lewis and h...nanoparticles into simple, inexpensive everyday pr...
...earchers led by Fei Hu, assistant professor of com...logy, is working to advance the integration of rad... as RFID, into cardiac sensor networks, a new wire...m will also work to enhance the security of the sy...ssibility of identity theft and cyber-terrorism. T...
Other Biology News:New research seeks to enhance quality and security of wireless telemedicine 2
Sheep Anti-Salmonella Thomasville Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Rabbit Anti-OCT6 Polyclonal Antibody, Unconjugated from Abcam
...rk, Super-Small! Capture high-resolution chemilum...oc-It Imaging System. High-sensitivity camera is c...ound noise and wide dynamic range for high quality...cabinet provides optimum conditions for chemilumin...
Biology Products: